Literature DB >> 21177400

Detection and investigation of invasive mould disease.

Manuel Cuenca-Estrella1, Matteo Bassetti, Cornelia Lass-Flörl, Zdenek Rácil, Malcolm Richardson, Thomas R Rogers.   

Abstract

A comprehensive review of diagnostic techniques for opportunistic systemic mycoses focused on invasive mould disease in immunocompromised patients is presented. We first analysed conventional diagnostic methods, such as microscopy examination, culture and radiology, underlining their limitations, which have led to the development of alternative methods, such as the detection of fungal components. Among these we highlight fungal antigen and DNA quantification, which make it possible to detect infections early and start appropriate treatment. We also briefly review the methods for carrying out susceptibility tests for antifungal drugs, including reference procedures, commercial techniques and their indications. Furthermore, we analyse the recommendations for therapeutic drug monitoring of antifungal agents in body fluids.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21177400     DOI: 10.1093/jac/dkq438

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  30 in total

1.  Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay.

Authors:  Riccardo Torelli; Maurizio Sanguinetti; Adrian Moody; Livio Pagano; Morena Caira; Elena De Carolis; Leonello Fuso; Gennaro De Pascale; Giuseppe Bello; Massimo Antonelli; Giovanni Fadda; Brunella Posteraro
Journal:  J Clin Microbiol       Date:  2011-10-19       Impact factor: 5.948

2.  Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity.

Authors:  Jorien D'Haese; Koen Theunissen; Edith Vermeulen; Hélène Schoemans; Greet De Vlieger; Liesbet Lammertijn; Philippe Meersseman; Wouter Meersseman; Katrien Lagrou; Johan Maertens
Journal:  J Clin Microbiol       Date:  2012-02-01       Impact factor: 5.948

3.  The management of febrile neutropenia in the posaconazole era: a new challenge?

Authors:  Livio Pagano; Morena Caira; Manuel Cuenca-Estrella
Journal:  Haematologica       Date:  2012-07       Impact factor: 9.941

4.  Performance of panfungal--and specific-PCR-based procedures for etiological diagnosis of invasive fungal diseases on tissue biopsy specimens with proven infection: a 7-year retrospective analysis from a reference laboratory.

Authors:  M J Buitrago; L Bernal-Martinez; M V Castelli; J L Rodriguez-Tudela; M Cuenca-Estrella
Journal:  J Clin Microbiol       Date:  2014-02-26       Impact factor: 5.948

Review 5.  Pneumonia in the neutropenic cancer patient.

Authors:  Scott E Evans; David E Ost
Journal:  Curr Opin Pulm Med       Date:  2015-05       Impact factor: 3.155

6.  Rapid and Sensitive Detection of Azole-Resistant Aspergillus fumigatus by Tandem Repeat Loop-Mediated Isothermal Amplification.

Authors:  Ling-Shan Yu; Jesus Rodriguez-Manzano; Kenny Malpartida-Cardenas; Thomas Sewell; Oliver Bader; Darius Armstrong-James; Matthew C Fisher; Pantelis Georgiou
Journal:  J Mol Diagn       Date:  2018-12-04       Impact factor: 5.568

7.  New Panfungal Real-Time PCR Assay for Diagnosis of Invasive Fungal Infections.

Authors:  Clara Valero; Laura de la Cruz-Villar; Óscar Zaragoza; María José Buitrago
Journal:  J Clin Microbiol       Date:  2016-09-14       Impact factor: 5.948

Review 8.  Diagnostic methods for invasive fungal diseases in patients with hematologic malignancies.

Authors:  Mary Mansour Riwes; John R Wingard
Journal:  Expert Rev Hematol       Date:  2012-12       Impact factor: 2.929

9.  A long-term survivor of disseminated Aspergillus and mucorales infection: an instructive case.

Authors:  Setareh Davoudi; Paolo Anderlini; Gregory N Fuller; Dimitrios P Kontoyiannis
Journal:  Mycopathologia       Date:  2014-08-03       Impact factor: 2.574

10.  Early Diagnosis of Cutaneous Mucormycosis Due to Lichtheimia corymbifera After a Traffic Accident.

Authors:  Tomas Tyll; Pavlina Lyskova; Vit Hubka; Martin Muller; Lubomir Zelenka; Martina Curdova; Inna Tuckova; Miroslav Kolarik; Petr Hamal
Journal:  Mycopathologia       Date:  2015-09-12       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.